DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.4, 2010-04, pp. : 507-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations

By Ellis Kyle J Stouffer George A McLeod Howard L Lee Craig R

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1799-1817

Future Medicine

Access to resources Recommend Favorite

Initiative to tackle counterfeit drugs announced by US FDA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

By Peters Eric J Motsinger-Reif Alison Havener Tammy M Everitt Lorraine Hardison Nicholas E Watson Venita G Wagner Michael Richards Kristy L Province Mike A McLeod Howard L

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1407-1415

Future Medicine

Access to resources Recommend Favorite

US FDA panel advises banning of two asthma drugs

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Clamp down on Rx drugs without US FDA approval

Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite